rs55639868

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_194248.3(OTOF):​c.710+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,613,840 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0088 ( 7 hom., cov: 33)
Exomes 𝑓: 0.010 ( 87 hom. )

Consequence

OTOF
NM_194248.3 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -1.39

Publications

5 publications found
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
OTOF Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-26502290-G-A is Benign according to our data. Variant chr2-26502290-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 48273.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00884 (1347/152306) while in subpopulation NFE AF = 0.0136 (928/68018). AF 95% confidence interval is 0.0129. There are 7 homozygotes in GnomAd4. There are 634 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.710+10C>T intron_variant Intron 7 of 46 ENST00000272371.7 NP_919224.1 Q9HC10-1
OTOFNM_001287489.2 linkc.710+10C>T intron_variant Intron 7 of 45 NP_001274418.1 Q9HC10-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.710+10C>T intron_variant Intron 7 of 46 1 NM_194248.3 ENSP00000272371.2 Q9HC10-1
OTOFENST00000403946.7 linkc.710+10C>T intron_variant Intron 7 of 45 5 ENSP00000385255.3 Q9HC10-5

Frequencies

GnomAD3 genomes
AF:
0.00886
AC:
1348
AN:
152188
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00962
Gnomad ASJ
AF:
0.0311
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00435
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00999
AC:
2506
AN:
250932
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.00197
Gnomad AMR exome
AF:
0.00943
Gnomad ASJ exome
AF:
0.0272
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00303
Gnomad NFE exome
AF:
0.0137
Gnomad OTH exome
AF:
0.0181
GnomAD4 exome
AF:
0.0102
AC:
14939
AN:
1461534
Hom.:
87
Cov.:
32
AF XY:
0.0104
AC XY:
7528
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33472
American (AMR)
AF:
0.0103
AC:
459
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0264
AC:
690
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00435
AC:
375
AN:
86232
European-Finnish (FIN)
AF:
0.00396
AC:
211
AN:
53314
Middle Eastern (MID)
AF:
0.0140
AC:
80
AN:
5708
European-Non Finnish (NFE)
AF:
0.0111
AC:
12374
AN:
1111890
Other (OTH)
AF:
0.0116
AC:
702
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
752
1504
2256
3008
3760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00884
AC:
1347
AN:
152306
Hom.:
7
Cov.:
33
AF XY:
0.00851
AC XY:
634
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41560
American (AMR)
AF:
0.00961
AC:
147
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0311
AC:
108
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00435
AC:
21
AN:
4828
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10620
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0136
AC:
928
AN:
68018
Other (OTH)
AF:
0.0104
AC:
22
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
68
136
203
271
339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
5
Bravo
AF:
0.00842
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 08, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 20, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

710+10C>T in exon 7 of OTOF: This variant is not expected to have clinical signi ficance because it is not located within the splice consensus sequence, has been identified in 1.4% (96/7020) of European American chromosomes and 0.2% (8/3738) of African American chromosomes in a broad population by the NHLBI Exome sequen cing project (http://evs.gs.washington.edu/EVS/; dbSNP rs55639868). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Feb 27, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 9 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.9
DANN
Benign
0.59
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55639868; hg19: chr2-26725158; API